Literature DB >> 26244541

Pregnancy-Related Mortality Resulting From Influenza in the United States During the 2009-2010 Pandemic.

William M Callaghan1, Andreea A Creanga, Denise J Jamieson.   

Abstract

OBJECTIVE: To estimate the burden of pregnancy-related mortality resulting from influenza A (H1N1)pdm09 virus infection during the 2009-2010 pandemic influenza season.
METHODS: Data from the Centers for Disease Control and Prevention's Pregnancy Mortality Surveillance System were used to identify women whose death during or shortly after pregnancy was attributed or likely attributed to the influenza A (H1N1)pdm09 virus from April 15, 2009, through June 30, 2010. We report the characteristics of these women and enumerate cases resulting in death as the pandemic began, peaked, and resolved.
RESULTS: During the pandemic season, we identified 915 pregnancy-related deaths and 4,911,297 live births. Seventy-five (8.2%) women died as a result of confirmed influenza A (H1N1)pdm09 infection deaths and 34 (3.7%) women as a result of possible influenza A (H1N1)pdm09 infection deaths. The pregnancy-related mortality ratio for confirmed and possible (combined) influenza A (H1N1)pdm09 infection deaths was 2.2 per 100,000 live births. Most deaths occurred during the 2009 calendar year with the peak of the distribution of deaths over time occurring in October 2009.
CONCLUSION: Twelve percent of pregnancy-related deaths were attributed to confirmed or possible influenza A (H1N1)pdm09 infection during the 2009-2010 pandemic season. Because prediction of pandemics is difficult, planning for prevention of influenza and care for those women affected are critical for preventing associated severe maternal morbidity and mortality. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2015        PMID: 26244541      PMCID: PMC4557717          DOI: 10.1097/AOG.0000000000000996

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.

Authors:  Pedro Moro; Jane Baumblatt; Paige Lewis; Janet Cragan; Naomi Tepper; Maria Cano
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

Review 2.  Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy.

Authors:  Eric J Chow; Richard H Beigi; Laura E Riley; Timothy M Uyeki
Journal:  Open Forum Infect Dis       Date:  2021-03-20       Impact factor: 3.835

3.  Pregnancy-Related Mortality in the United States, 2011-2013.

Authors:  Andreea A Creanga; Carla Syverson; Kristi Seed; William M Callaghan
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

Review 4.  Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes.

Authors:  Alice Panchaud; Miloš Stojanov; Anne Ammerdorffer; Manon Vouga; David Baud
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 5.  Incidence of influenza virus infection among pregnant women: a systematic review.

Authors:  Mark A Katz; Bradford D Gessner; Jeanene Johnson; Becky Skidmore; Marian Knight; Niranjan Bhat; Helen Marshall; David J Horne; Justin R Ortiz; Deshayne B Fell
Journal:  BMC Pregnancy Childbirth       Date:  2017-05-30       Impact factor: 3.007

6.  Extra-corporeal membrane oxygenation as an indispensable tool for a successful treatment of a pregnant woman with H1N1 infection in Brazil.

Authors:  Rodrigo T Amancio; Celina Machado Acra; Vicente Cés de Souza Dantas
Journal:  Respir Med Case Rep       Date:  2017-02-04

7.  Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.

Authors:  Miloje Savic; Jennifer L Dembinski; Ida Laake; Olav Hungnes; Rebecca Cox; Fredrik Oftung; Lill Trogstad; Siri Mjaaland
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

8.  H1N1 Infection in Pregnancy; A Retrospective Study of Feto-Maternal Outcome and Impact of the Timing of Antiviral Therapy.

Authors:  Naser Al-Husban; Nathir Obeidat; Oqba Al-Kuran; Khaled Al Oweidat; Faris Bakri
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-03-01       Impact factor: 2.576

Review 9.  Cardiovascular Outcomes in Advanced Maternal Age Delivering Women. Clinical Review and Medico-Legal Issues.

Authors:  Daniele De Viti; Antonio Malvasi; Francesco Busardò; Renata Beck; Simona Zaami; Enrico Marinelli
Journal:  Medicina (Kaunas)       Date:  2019-09-29       Impact factor: 2.430

Review 10.  Dismantling the Taboo against Vaccines in Pregnancy.

Authors:  Maurizio de Martino
Journal:  Int J Mol Sci       Date:  2016-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.